The biological role of AKT serine/threonine kinase 2 in lung cancer

被引：0
|
作者：
Serilmez, M. [1 ]
Karaman, S. [2 ]
Soydinc, H. Oguz [1 ]
Yasasever, C. Tilgen [1 ]
Bilgin, E. [1 ]
Duranyildiz, D. [1 ]
Yasasever, V. [1 ]
机构：
[1] Istanbul Univ, Inst Oncol, Basic Oncol Dept Canc Biochem, Istanbul, Turkey
[2] Istanbul Univ, Inst Oncol, Dept Clin Oncol, Istanbul, Turkey
来源：
EUROPEAN JOURNAL OF CANCER | 2017年 / 72卷
关键词：
D O I：
10.1016/S0959-8049(17)30528-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1332A
引用
收藏
页码：S138 / S138
页数：1
相关论文
共 50 条
  • [21] Activation of the serine/threonine protein kinase AKT during the progression of colorectal neoplasia
    Saglam, Ozlen
    Garrett, Christopher R.
    Boulware, David
    Sayegh, Zena
    Shibata, David
    Malafa, Mokenge
    Yeatman, Timothy
    Cheng, Jin Q.
    Sebti, Said
    Coppola, Domenico
    CLINICAL COLORECTAL CANCER, 2007, 6 (09) : 652 - 656
  • [22] The role of miR-125b-5p- AKT serine/threonine kinase 1 axis in osteosarcoma
    Bozgeyik, Ibrahim
    Karadag, Abdullah
    GENE REPORTS, 2020, 21
  • [23] MicroRNA-137-regulated AKT serine/threonine kinase 2 inhibits tumor growth and sensitizes cisplatin in patients with non-small cell lung cancer
    Lu, Zhuming
    Wang, Minghui
    Wu, Shuoyun
    Ye, Min
    Lin, Zhichao
    Shun, Tao
    Duan, Chuxiao
    ONCOLOGY LETTERS, 2018, 16 (02) : 1876 - 1884
  • [24] Absence of the mutation of serine/threonine kinase genes AKT2 and MYLK2 in acute leukemias
    Soung, Young Hwa
    Lee, Jong Woo
    Kim, Su Young
    Nam, Suk Woo
    Kim, Sang Ho
    Lee, Jung Young
    Yoo, Nam Jin
    Lee, Sug Hyung
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 77 (02) : 175 - 176
  • [25] ATM Serine/Threonine Kinase and its Role in Pancreatic Risk
    Nanda, Neha
    Roberts, Nicholas J.
    GENES, 2020, 11 (01)
  • [26] MicroRNA-215 acts as a tumor suppressor in breast cancer by targeting AKT serine/threonine kinase 1
    Yao, Jian
    Zhang, Ping
    Li, Jin
    Xu, Wei
    ONCOLOGY LETTERS, 2017, 14 (01) : 1097 - 1104
  • [27] RETRACTED ARTICLE: TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT
    Richard Hill
    Patricia A. Madureira
    Bibiana Ferreira
    Inês Baptista
    Susana Machado
    Laura Colaço
    Marta dos Santos
    Ningshu Liu
    Ana Dopazo
    Selma Ugurel
    Angyal Adrienn
    Endre Kiss-Toth
    Murat Isbilen
    Ali O. Gure
    Wolfgang Link
    Nature Communications, 8
  • [28] Retraction Note: TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT
    Richard Hill
    Patricia A. Madureira
    Bibiana Ferreira
    Inês Baptista
    Susana Machado
    Laura Colaҫo
    Marta dos Santos
    Ningshu Liu
    Ana Dopazo
    Selma Ugurel
    Angyal Adrienn
    Endre Kiss-Toth
    Murat Isbilen
    Ali O. Gure
    Wolfgang Link
    Nature Communications, 14
  • [29] Molecular cloning, expression and characterization of the human serine/threonine kinase Akt-3
    Masure, S
    Haefner, B
    Wesselink, JJ
    Hoefnagel, E
    Mortier, E
    Verhasselt, P
    Tuytelaars, A
    Gordon, R
    Richardson, A
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 265 (01): : 353 - 360
  • [30] Molecular analysis of the serine/threonine kinase Akt and its expression in the mosquito Aedes aegypti
    Riehle, MA
    Brown, MR
    INSECT MOLECULAR BIOLOGY, 2003, 12 (03) : 225 - 232
12345